Filing Details
- Accession Number:
- 0000950170-24-014537
- Form Type:
- 5
- Zero Holdings:
- No
- Publication Time:
- 2024-02-13 16:05:15
- Reporting Period:
- 2023-12-31
- Accepted Time:
- 2024-02-13 16:05:15
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1743881 | Bridgebio Pharma Inc. | BBIO | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1855608 | Hannah Valantine | C/O Bridgebio Pharma, Inc. 3160 Porter Dr., Suite 250 Palo Alto CA 94304 | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-12-28 | 1,891 | $13.18 | 1,891 | No | 5 | P | Indirect | By Spouse |
| Common Stock | Acquisiton | 2021-12-28 | 1,542 | $12.68 | 3,433 | No | 5 | P | Indirect | By Spouse |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 5 | P | Indirect | By Spouse |
| No | 5 | P | Indirect | By Spouse |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 1,764 | Direct |
Billionaire Hedge Funds
